BPA was one of six chemicals identified because of the lack of data to enable assessment on the risks posed to human health and/or the environment.
MSC is responsible for resolving differences of opinions among Member States and on proposals for the identification of Substances of Very High Concern (SVHCs).
The committee agreed that the European Chemicals Agency (ECHA) should request an in vitro skin absorption study to assess the risk to consumers and information on emissions and environmental exposure will be requested to assess environmental impact.
Information will help finalise the risk assessment and decide whether further risk management measures are needed.
Denmark is evaluating the substance under the Community Rolling Action Plan (CoRAP) with a decision due in 2015.
Germany is also looking at BPA under CoRAP as a suspected endocrine disruptor, exposure/wide dispersive use, consumer use and high aggregated tonnage last year.